English
Home > Products > 5-oxo-6-triphenylphosphoranylidenehexanoate

China 5-oxo-6-triphenylphosphoranylidenehexanoate Factory

Bear "Customer very first, Quality first" in mind, we work closely with our customers and supply them with efficient and professional services for 5-oxo-6-triphenylphosphoranylidenehexanoate,CAS NO 147118-35-2,147118-35-2,Rosuvastatin intermediate,Rosuvastatin advance intermediate, We have been self-assured to make excellent achievements within the future. We've been looking forward to becoming one within your most trusted suppliers.
5-oxo-6-triphenylphosphoranylidenehexanoate, Further, we're supported by highly experienced and knowledgeable professionals, who have immense expertise in their respective domain. These professionals work in close coordination with each other to provide our clients an effective range of products and solutions.

Related Products

Hot Products

  • Molybdenyl acetylacetonate

    Molybdenyl acetylacetonate

    Product Name:Molybdenyl acetylacetonate
    Molecular Formula:C10H14MoO6
    Molecular Weight:326.15
    CAS Registry Number:17524-05-9
  • 4-Bromofluorobenzene

    4-Bromofluorobenzene

    Product Name:4-Bromofluorobenzene
    Molecular Formula:C6H4BrF
    Molecular Weight:175
    CAS Registry Number:460-00-4
  • 1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrilehydrochloride

    1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrilehydrochloride

    Product Name:1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrilehydrochloride
    Molecular Formula:C7H11ClN4
    Molecular Weight:186.64
    CAS Registry Number:1643141-20-1
  • Fmoc-HoArg(Pbf)-OH

    Fmoc-HoArg(Pbf)-OH

    Product Name:Fmoc-HoArg(Pbf)-OH
    Molecular Formula:C35H42N4O7S
    Molecular Weight:662.8
    CAS Registry Number:401915-53-5
  • 2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID

    2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID

    Product Name:2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID
    Molecular Formula:C7H5BrFNO2
    Molecular Weight:234.02
    CAS Registry Number:874784-14-2
  • 1-Hexadecanol

    1-Hexadecanol

    Product Name:1-Hexadecanol
    Molecular Formula:C16H34O
    Molecular Weight:242.44
    CAS Registry Number:36653-82-4
  • Related Blog
  • Reviews

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept